CompletedNCT05532683
This study exists to see whether psychoeducation, a guided learning and support program, is workable and worth testing more broadly. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve sleep, daily rhythms, and longer-term stability.
SchizophreniaOtherFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia
CompletedNCT06518330
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 5 Years to 17 Years
- Countries
- France
- Sponsor
- University Hospital, Caen
- Condition
- Schizophrenia
RecruitingNCT06505564
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.
SchizophreniaOtherOver 18 Years
- Countries
- Hungary, Poland, Spain
- Sponsor
- Semmelweis University
- Condition
- Schizophrenia
RecruitingNCT06505668
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- India
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Condition
- Schizophrenia
CompletedNCT05911529
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Switzerland
- Sponsor
- Psychiatric University Hospital, Zurich
- Condition
- Schizophrenia
Not Yet RecruitingNCT06501339
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Global
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Condition
- Schizophrenia
CompletedNCT06502509
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 20 Years to 65 Years
- Countries
- Taiwan
- Sponsor
- TsaoTun Psychiatric Center, Department of Health, Taiwan
- Condition
- Schizophrenia
RecruitingNCT06494124
This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- India
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Condition
- Schizophrenia
CompletedNCT05193578
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Denmark
- Sponsor
- Jan Frystyk
- Condition
- Schizophrenia
CompletedNCT02969382
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- Hungary, Romania, Russian Federation, Ukraine, United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT02970929
This study exists to understand how the medication Safety holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication Safety in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- Hungary, Romania, Russian Federation, Ukraine, United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
RecruitingNCT06482918
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 59 Years
- Countries
- Chile
- Sponsor
- University of Chile
- Condition
- Schizophrenia
RecruitingNCT06482554
This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Louisiana State University Health Sciences Center Shreveport
- Condition
- Schizophrenia
CompletedNCT04239612
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Sweden
- Sponsor
- Karolinska Institutet
- Condition
- Schizophrenia
CompletedNCT04072354
This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 13 Years to 65 Years
- Countries
- Bulgaria, Colombia, Russian Federation, Serbia, Ukraine, United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT01940159
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT01972711
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United Kingdom
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT04865835
This study exists to see whether acceptance and commitment therapy, a talking treatment, can play a useful role in care. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT04369391
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT05463770
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT05402111
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT05848700
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT05542264
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT01994473
This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand how people respond to blood tests and biological markers in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT04092686
This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Bulgaria, Croatia, Latvia, Russian Federation, Serbia, Ukraine, United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia